Allianz Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,000
Closed -$840K 2519
2022
Q1
$840K Hold
30,000
﹤0.01% 1933
2021
Q4
$819K Hold
30,000
﹤0.01% 1988
2021
Q3
$816K Buy
+30,000
New +$742K ﹤0.01% 2027
2020
Q3
Sell
-263,583
Closed -$3.57M 2479
2020
Q2
$3.57M Buy
+263,583
New +$3.07M ﹤0.01% 1353
2019
Q4
Sell
-37,581
Closed -$639K 2889
2019
Q3
$639K Buy
+37,581
New +$684K ﹤0.01% 2291
2019
Q2
Sell
-151,590
Closed -$4.87M 2803
2019
Q1
$4.87M Sell
151,590
-28,483
-16% -$881K ﹤0.01% 1471
2018
Q4
$5.07M Sell
180,073
-52,108
-22% -$1.53M 0.01% 1406
2018
Q3
$6.67M Buy
232,181
+108,576
+88% +$3.26M 0.01% 1432
2018
Q2
$4.63M Sell
123,605
-557
-0.4% -$21.9K ﹤0.01% 1562
2018
Q1
$4.88M Sell
124,162
-2,248
-2% -$82.1K ﹤0.01% 1545
2017
Q4
$4.1M Sell
126,410
-1,519
-1% -$45.6K ﹤0.01% 1719
2017
Q3
$3.98M Buy
127,929
+283
+0.2% +$8.38K ﹤0.01% 1728
2017
Q2
$3.57M Sell
127,646
-1,396
-1% -$31.6K ﹤0.01% 1744
2017
Q1
$2.21M Buy
129,042
+1,031
+0.8% +$14.4K ﹤0.01% 1960
2016
Q4
$1.55M Sell
128,011
-20,632
-14% -$267K ﹤0.01% 2054
2016
Q3
$2.35M Sell
148,643
-7,295
-5% -$110K ﹤0.01% 1933
2016
Q2
$2.02M Buy
155,938
+1,098
+0.7% +$17.2K ﹤0.01% 1916
2016
Q1
$2.94M Sell
154,840
-637,346
-80% -$11.5M ﹤0.01% 1641
2015
Q4
$17.8M Sell
792,186
-41,397
-5% -$818K 0.02% 804
2015
Q3
$19.5M Buy
833,583
+376,204
+82% +$10.4M 0.02% 715
2015
Q2
$13.1M Buy
457,379
+215,263
+89% +$5.64M 0.01% 983
2015
Q1
$6.25M Buy
242,116
+167,475
+224% +$3.83M 0.01% 1133
2014
Q4
$1.39M Buy
74,641
+22,522
+43% +$405K ﹤0.01% 1705
2014
Q3
$808K Buy
+52,119
New +$785K ﹤0.01% 1728

Allianz Asset Management's XENT Position: Q2 2022 in Review

Allianz Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 30,000 shares — an estimated $840K sold.

Allianz Asset Management first reported a position in XENT in Q3 2014 and held it in 24 quarters. The position peaked at $19.5M in Q3 2015. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Allianz Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Allianz Asset Management sold 30,000 Intersect ENT, Inc shares in Q2 2022, an estimated $840K.
  • Allianz Asset Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 24 quarters.
  • Allianz Asset Management's Intersect ENT, Inc position peaked at $19.5M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Allianz Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.